Galmed Pharmaceuticals Ltd. (GLMD) - Financials, balance sheet (quarterly)

1.31 USD

0.03

2.34%

Last update Sep 5, 11:35 AM EDT

Main market

Day range

1.31

1.26

1.31

Previous close

1.28000

Open

1.27

Access this stock data via API

Galmed Pharmaceuticals Ltd.

1.31

0.03

2.34%

Financials

Balance sheet

Fiscal date	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Total assets	22.9M	18.7M	18.5M	21.0M
Current assets	21.1M	16.3M	16.1M	17.7M
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	5.0M	4.8M	4.7M	9.7M
Other short term investments	15.6M	11.0M	10.7M	7.4M
Accounts receivable	—	—	—	—
Other receivables	433K	447K	209K	426K
Inventory	—	—	—	—
Prepaid assets	—	—	463K	—
Restricted cash	123K	122K	121K	119K
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	—	—	—	—
Non current assets	1.9M	2.4M	2.4M	3.3M
Properties	—	—	737K	—
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	130K	—
Construction in progress	—	—	—	—
Leases	—	—	236K	—
Accumulated depreciation	—	—	-1.1M	—
Goodwill	—	—	—	—
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	—	—	—	—
Investments and advances	1.6M	2.1M	2.1M	3.3M
Other non current assets	—	—	—	—
Total liabilities	2.4M	1.8M	2.2M	2.5M
Current liabilities	2.4M	1.8M	2.2M	2.5M
Accounts payable	1.4M	1.3M	1.3M	1.3M
Accrued expenses	—	—	256K	—
Short term debt	—	—	—	—
Deferred revenue	—	—	—	—
Tax payable	—	—	—	—
Pensions	—	—	603K	—
Other current liabilities	—	—	—	—
Non current liabilities	0	0	0	0
Long term provisions	—	—	—	—
Long term debt	—	—	—	—
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	—	—	—
Shareholders equity
Common stock	2.7M	1.0M	742K	665K
Retained earnings	-204.1M	-201.6M	-200.5M	-197.3M
Other shareholders equity	-403K	-397K	-416K	-342K
Total shareholders equity	20.5M	16.9M	16.3M	18.4M
Additional paid in capital	222.3M	217.8M	216.5M	215.4M
Treasury stock	—	—	—	—
Minority interest	—	—	—	—